ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638850; 2) Community: the network communities that were significantly associated with the response to NSC 638850; 3) Molecule: the relationships between components within communities and NSC 638850; 4) MDR: the compounds that were significantly associated with the NSC 638850.

NSC Compound Enrichment Correlation
NSC 696073 Null 0.0480633950058475 -0.062455096
NSC 699934 Null 0.0480633950058475 -0.0966549
NSC 715407 Null 0.0480633950058475 0.038959363
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 0.33238612
NSC 725098 Null 0.0480633950058475 -0.27835038
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0480633950058475 -0.018977459
NSC 744688 Null 0.0480633950058475 -0.26897555
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0480633950058475 -0.26998862
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0480633950058475 -0.38400187
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0480633950058475 -0.29962104
Total:63  Current:62    [First] [Prev] [Next] [Last]